Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination

This publication has 30 references indexed in Scilit:

• Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
  PLOS ONE, 2008
• Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
  Vaccine, 2008
• Seasonal inactivated influenza virus vaccines
  Vaccine, 2008
• Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus
  Journal of Virology, 2008
• Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
  Proceedings of the National Academy of Sciences, 2008
• Cross-subtype Immunity against Avian Influenza in Persons Recently Vaccinated for Influenza
  Emerging Infectious Diseases, 2008
• Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
  Vaccine, 2007
• Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans
  PLoS Medicine, 2007
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
  The Lancet, 2006
• Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in mice
  European Journal of Immunology, 1980